Laurion Capital Management LP Ligand Pharmaceuticals Inc Transaction History

Laurion Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 13, 2019	SELL	$107.38 - $129.34 $1.31 Million - $1.58 Million	-12,187 Closed	0 $0
Q1 2019 May 08, 2019	BUY	$105.93 - $142.47 $1.29 Million - $1.74 Million	12,187 New	12,187 $1.53 Million
Q2 2018 Aug 13, 2018	SELL	$150.77 - $207.98 $301,540 - $415,960	-2,000 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$138.63 - $182.62 $277,260 - $365,240	2,000 New	2,000 $330,000

258

18.1M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.95B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.